UBS Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.05M | Buy |
|
|||||
|
2023
Q3 | $1.44M | Sell |
|
|||||
|
2023
Q2 | $4.51M | Buy |
|
|||||
|
2023
Q1 | $3.03M | Sell |
|
|||||
|
2022
Q4 | $6.33M | Buy |
|
|||||
|
2022
Q3 | $1.5M | Sell |
|
|||||
|
2022
Q2 | $3.34M | Buy |
|
|||||
|
2022
Q1 | $660K | Sell |
|
|||||
|
2021
Q4 | $5.82M | Buy |
|
|||||
|
2021
Q3 | $5.11M | Buy |
|
|||||
|
2021
Q2 | $823K | Sell |
|
|||||
|
2021
Q1 | $1.72M | Sell |
|
|||||
|
2020
Q4 | $3.14M | Buy |
|
|||||
|
2020
Q3 | $2.09M | Sell |
|
|||||
|
2020
Q2 | $2.82M | Buy |
|
|||||
|
2020
Q1 | $1.21M | Sell |
|
|||||
|
2019
Q4 | $2.32M | Sell |
|
|||||
|
2019
Q3 | $6.46M | Buy |
|
|||||
|
2019
Q2 | $2.12M | Buy |
|
|||||
|
2019
Q1 | $221K | Sell |
|
|||||
|
2018
Q4 | $7.42M | Buy |
|
|||||
|
2018
Q3 | $1.37M | Buy |
|
|||||
|
2018
Q2 | $123K | Sell |
|
|||||
|
2018
Q1 | $1.85M | Buy |
|
|||||
|
2017
Q4 | $460K | Buy |
|
|||||
|
2017
Q3 | $171K | Sell |
|
|||||
|
2017
Q2 | $93K | Buy |
|
|||||
|
2017
Q1 | $117K | Sell |
|
|||||
|
2016
Q4 | $130K | Buy |
|
|||||
|
2016
Q3 | $142K | Sell |
|
|||||
|
2016
Q2 | $120K | Buy |
|
|||||
|
2016
Q1 | $429K | Sell |
|
|||||
|
2015
Q4 | $1.24M | Buy |
|
|||||
|
2015
Q3 | $575K | Sell |
|
|||||
|
2015
Q2 | $576K | Sell |
|
|||||
|
2015
Q1 | $581K | Buy |
|
|||||
|
2014
Q4 | $218K | Buy |
|